GFI Stock DD Gold Fields Ltd. Sunday, April 27, 2014 8:52:12

New Post Public Reply Private Reply Replies (0) Message Board

Apr 27, 2014 at 9:52 PM

GFI Gold Fields Ltd. $GFI Company Overview

Stock Message Board http://investorshangout.com/search?q=GFI&...mp;yt1=Go!

Last Updated: Sunday, April 27, 2014 8:52:12 PM

Gold Fields Ltd. GFI Current Price and Quotes
Last Price 4.32
Previous Close 4.03 Open 4.08
Daily Range 4.06 - 4.33 52wk Range 2.92 - 7.81
Volume 4,080,819 Dividend 0.0867
Average Vol (3m) 5,898,973 Yield 2.0069
Gold Fields Ltd. GFI

Gold Fields Ltd. GFI
Gold Fields Ltd. GFI

Gold Fields Ltd. GFI

Gold Fields Ltd. GFI Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Jun 30, 2010
Total Revenue 5,551,800 5,800,100 2,564,200 4,164,300
Cost of Revenue 3,190,400 2,989,000 1,450,300 2,573,600
Gross Profit 2,361,400 2,811,100 1,113,900 1,590,700
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 164,200 165,700 69,000 55,400
Non-Recurring Items 176,900 134,900 53,200 86,600
Other 758,100 770,200 400,300 650,400
Operating Income 1,262,200 1,740,300 591,400 798,300
Income From Continuing Operations

Add'l Income/Expense Items (196,000) (178,200) (364,900) 118,300
Earnings Before Interest and Tax 1,065,700 1,562,500 225,800 916,300
Interest Expense 70,100 54,300 31,700 65,200
Earnings Before Tax 995,600 1,508,200 194,100 851,100
Income Tax 291,900 552,000 133,800 358,400
Minority Interest (1,800) 71,500 53,300 79,300
Equity Earnings Unconsolidated Subsidiary (51,700) (2,800) 4,900 (22,700)
Net Income Cont. Operations 653,800 881,900 11,900 390,700
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 654,300 881,500 12,600 391,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 654,300 881,500 12,600 391,000

Gold Fields Ltd. GFI Recent News

Apr 14, 2014 Pele Mountain Announces Option Grant
Apr 10, 2014 Gold Fields Q1 2014 Guidance Update
Apr 10, 2014 Pele Mountain Enters Into Access Agreement to Sample Elliot Lake Mine Tailings for Rare Earths
Apr 1, 2014 Coverage of Active Equities -- Research on Gold Fields, MasterCard, BB&T Corp., and SandRidge Energy
Mar 31, 2014 Gold Fields Publishes Integrated Annual Review for the Year to 31 December 2013
Mar 19, 2014 Pele Mountain Updates Progress at Its Eco Ridge Mine Rare Earth and Uranium Project
Mar 7, 2014 Pele Mountain Shareholders Approve All Matters Presented at the Annual and Special Meeting of the Shareholders
Mar 7, 2014 Technical Insight - Top Gainers: Boyd Gaming, GFI Gold Fields, Hanwha SolarOne and Hawaiian Holdings
Mar 3, 2014 Pele Mountain Presents Testimony to Parliamentary Committee on Natural Resources
Feb 24, 2014 Gold Fields Declares 2013 Mineral Reserves and Mineral Resources

1
2
next >

GFI Gold Fields Ltd. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=GFI&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/GFI/quote
Stock Chart http://www.otcmarkets.com/stock/GFI/chart
Company Info http://www.otcmarkets.com/stock/GFI/company-info
Recent News http://www.otcmarkets.com/stock/GFI/news
Financials http://www.otcmarkets.com/stock/GFI/financials
Filings and Disclosure http://www.otcmarkets.com/stock/GFI/filings
Short Sales http://www.otcmarkets.com/stock/GFI/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/GFI/insider-transactions
Research Reports http://www.otcmarkets.com/stock/GFI/research
Summary http://finance.yahoo.com/q?s=GFI
Historical Prices http://finance.yahoo.com/q/hp?s=GFI+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=GFI
Basic Chart http://finance.yahoo.com/q/bc?s=GFI+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GFI+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=GFI+Headlines
Press Releases http://finance.yahoo.com/q/p?s=GFI+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=GFI+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=GFI+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=GFI+Industry
Major Holders http://finance.yahoo.com/q/mh?s=GFI+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=GFI+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=GFI+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=GFI
Balance Sheet http://finance.yahoo.com/q/bs?s=GFI
Cash Flow http://finance.yahoo.com/q/cf?s=GFI+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/GFI
Market Watch http://www.marketwatch.com/investing/stock/GFI
Bloomberg http://www.bloomberg.com/quote/GFI:US
Morningstar http://quotes.morningstar.com/stock/s?t=GFI
Bussinessweek http://investing.businessweek.com/research/st...ticker=GFI
Barchart http://www.barchart.com/quotes/stocks/GFI
OTC Short Report http://otcshortreport.com/index.php?index=GFI
Investopedia http://www.investopedia.com/markets/stocks/GFI/?wa=0

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...